CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
Clinical trials for CASTRATION-RESISTANT PROSTATE CANCER (CRPC) explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATE CANCER (CRPC) trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATE CANCER (CRPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made vaccine takes on tough prostate cancer
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis early-phase study tests a personalized vaccine made from each patient's own immune cells and tumor markers. It aims to train the body to fight advanced prostate cancer that has stopped responding to standard treatments. About 9 to 18 men will receive four doses over eight we…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
Phase: PHASE1 • Sponsor: Changhai Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 02:09 UTC
-
New imaging agent aims to spot Hard-to-Find cancers
Diagnosis TerminatedThis study was designed to test a new imaging agent called 111In-ABD147 that targets a protein (DLL3) found on many solid tumors, including prostate cancer and neuroendocrine tumors. The goal was to see if it could help detect metastatic cancer using SPECT scans. However, the stu…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated May 22, 2026 14:03 UTC